FIELD: biotechnology.
SUBSTANCE: described is a group of inventions comprising a liposome for enhancing the effectiveness of a vaccine, substantially free of saponin, an adjuvant composition for enhancing the effectiveness of the vaccine containing said liposome, a vaccine composition for potentiating an immune response, comprising said liposome, a method for inducing an immune response to BVDV in cattle, method of preventing Eimeria oocyst release in poultry infected by Eimeria, a method of producing said liposome. In one embodiment, the liposome is substantially free of saponin, wherein saponin is either absent, or is present in an amount less than determined, and comprises an external lipid two-layer membrane and an inner chamber.
EFFECT: invention extends the range of agents for enhancing immune response inducing.
23 cl, 25 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS | 2021 |
|
RU2813150C2 |
| MULTIVALENT AND MULTI-SPECIFIC 41BB-BINDING FUSED PROTEINS | 2017 |
|
RU2789648C2 |
| MULTIVALENT AND MULTISPECIFIC HYBRID PROTEINS THAT BIND TO DR5 | 2016 |
|
RU2748620C2 |
| ATRIAL NATRIURETIC PEPTIDE GRAFTED ANTIBODIES | 2019 |
|
RU2822433C2 |
| IMMUNOMODULATORY FUSED PROTEINS AND THEIR APPLICATION METHODS | 2016 |
|
RU2755227C2 |
| FUSED PROTEINS WITH ALBUMIN-BINDING DOMAINS | 2018 |
|
RU2786444C2 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA, AND COMPOSITIONS THEREOF, COMBINATIONS AND METHODS OF USING | 2015 |
|
RU2720282C1 |
| ANTIBODIES TO TAU AND THEIR USE | 2018 |
|
RU2787779C2 |
| PARTICLES CONJUGATED TO PEPTIDE | 2014 |
|
RU2813163C2 |
| BIOLOGICAL MATERIALS FOR MODULATING IMMUNE RESPONSES | 2017 |
|
RU2770060C2 |
